Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 12

Results For "acquisition"

843 News Found

Ami Organics bets on strategic acquisitions as its IPO opens on Sept 1
News | September 01, 2021

Ami Organics bets on strategic acquisitions as its IPO opens on Sept 1

The company aims to continue its expansion via organic and inorganic routes to increase production capacity and product portfolio


Aurobindo Pharma calls off its acquisition of Cronus Pharma
News | August 21, 2021

Aurobindo Pharma calls off its acquisition of Cronus Pharma

The acquisition was expected to be completed in eight weeks, and it would have provided it with a foothold in the US $ 48 billion global animal health market


Bayer strengthens drug discovery platform through acquisition of Vividion Therapeutics
Biotech | August 10, 2021

Bayer strengthens drug discovery platform through acquisition of Vividion Therapeutics

Purchase price of US $ 1.5 billion upfront and up to USD 500 million in success-based milestone payments


Metropolis Healthcare gets approval for acquisition of Dr. Ganesan's Hitech Diagnostic Centre
News | July 11, 2021

Metropolis Healthcare gets approval for acquisition of Dr. Ganesan's Hitech Diagnostic Centre

In the interim, the statutory approvals obtained by the company under SEBI ICDR have lapsed in accordance with applicable law and are required to be re-obtained


Thermo Fisher completes acquisition of Henogen
News | January 16, 2021

Thermo Fisher completes acquisition of Henogen

Novasep's viral vector business is an excellent strategic fit as Thermo Fisher continues to expand its capabilities for cell and gene vaccines and therapies globally," said Michel Lagarde, executive vice president, Thermo Fisher.


GSK launches $124-a-share takeover bid for cancer biotech Nuvalent
News | June 26, 2026

GSK launches $124-a-share takeover bid for cancer biotech Nuvalent

The offer is being made through Harmony Row Acquisition Co., a wholly owned GSK subsidiary, and targets all outstanding Class A and Class B shares of Nuvalent


Merck KGaA to acquire Bio-Techne for $11.3 Billion in major life sciences deal
Biopharma | June 26, 2026

Merck KGaA to acquire Bio-Techne for $11.3 Billion in major life sciences deal

Acquisition strengthens Merck's life sciences portfolio, expands capabilities across research and biopharma manufacturing


Merck names Miguel Alcalde to lead global commercial strategy;  Monia Vial to head North America
People | June 26, 2026

Merck names Miguel Alcalde to lead global commercial strategy; Monia Vial to head North America

The appointments come as Andrew Paterson, who has spent 31 years with the company, prepares to retire


SuperLiving raises $7 million in Series A to scale AI-powered preventive health platform
Startup | June 25, 2026

SuperLiving raises $7 million in Series A to scale AI-powered preventive health platform

The company plans to use this funding to boost AI capabilities, expand vernacular content ecosystem, accelerate product development, and scale user acquisition across Tier 2 and Tier 3 markets


Teva submits FDA application for experimental Tourette syndrome treatment ecopipam
Drug Approval | June 23, 2026

Teva submits FDA application for experimental Tourette syndrome treatment ecopipam

The filing is backed by positive Phase 3 results recently published in JAMA Neurology